. A currently-used test is based on measuring the druginduced inhibition of the colony-forming ability of tumour cells grown in soft agar (Hamburger & Salmon, 1977 (Vindelov et al., 1982 (Vindelov et al., , 1983 (Dan0, 1971; 1972a; 1972b; Skovsgaard, 1977a; 1977b; 1979) were kindly supplied by Dr. T. Skovsgaard, Dept. Internal Medicine, Finsen Institute, Copenhagen. One of the tumours ("wild-type") was sensitive to adriamycin (as well as to other anthracyclines) and was previously found to be hypotetraploid. The other two tumours were adriamycin-resistant and were previously characterized as hypotetraploid and hyperdiploid, respectively. Tumour cells used in the experiments were harvested 6-8 days after i.p.
A major problem in cancer chemotherapy is the wide range of responsiveness even for tumours of identical histopathological types (Salmon et al., 1978; Wilson & Neal, 1981) . Methods for individually-guided therapy based on in vitro sensitivity testing of the tumours would therefore be of great importance, and the development of a predictive test for chemosensitivity has a high priority in cancer research (Hamburger, 1981) . A currently-used test is based on measuring the druginduced inhibition of the colony-forming ability of tumour cells grown in soft agar (Hamburger & Salmon, 1977) . However, the very low colonyforming efficiency of human malignant tumours involves the risk of the test not being representative of the majority of the tumour cells. Furthermore, observation periods of several weeks are required before results are obtained.
In recent years, the development of flow cytometric DNA analysis has made it possible to obtain rapid information on tumour DNA index, and on the percentage of cells in the cell cycle phases (Barlogie et al., 1978; Christensen et al., 1978) . Furthermore, drug-induced perturbations of the cell cycle distribution of tumours responding to chemotherapy were demonstrated by flow cytometric DNA analysis on tumour tissue obtained by sequential fine-needle aspirations (Vindelov et al., 1982 (Vindelov et al., , 1983 (Dan0, 1971; 1972a; 1972b; Skovsgaard, 1977a; 1977b; 1979) were plated on top of a layer of hardened 0.25% agar (Difco) containing 26% FBS, 2.5% (by vol) sheep red blood cells, and mercapto-ethanol (5 x 10-M) and incubated at 37°C in a humidified atmosphere of 5% CO2 in 95% air. Cells for flow cytometric DNA analysis were harvested with a pipette. After gentle washing of the agar surface and reharvesting, the dishes appeared cell-free by microscopic examination. Duplicates of samples were analysed separately from day 0-18.
The adriamycin incubation was performed with two different procedures. (Vindel0v et al., 1983) . The DNA distribution was analysed with a computer programme calculating the fractions of cells in the cell cycle phases (Christensen et al., 1978) . In this study the number of cells analysed for each histogram was approximately 5x 104. The CV of the G1 peak was calculated for all histograms and ranged from 0.02-0.05.
Results
The initial DNA histograms (Day 0) are shown in Figure 1 , and the changes in the cell cycle phases of The effect on the G2 + M fraction of lhincubation with different concentrations of adriamycin is shown in Figure 3 . In the wild-type tumour adriamycin doses from 5 x 10-4-5 x 10-2 mgml-l resulted in G2+M accumulation, and the maximum perturbation was found for the dose, 5 x 10-3 mgml-1. After Day 1 or 2 the harvest resulted in low cell yields and much debris with doses where G2 + M accumulations were found. This phenomenon was probably caused by druginduced cell kill, and flow cytometry was therefore not possible. The maximum dose applied (101 mg ml-1) caused no detectable changes in the DNA histograms. In contrast to this, a high drug concentration (10-1 mgml-P) in the 2 resistant tumours resulted in an increase of G2 + M cells, decreasing to control values on Day 4. Adriamycin concentrations < 10-2mg ml-had no effect on the G2 + M fraction. resulted in an accumulation in the G2 + M phase. In contrast to the 1 h experiment, the harvest resulted in sufficient cell yields for flow cytometric DNA analysis until Day 3 with no indication of cell death. In the 2 resistant tumours continuous incubation resulted in no detectable effect on the G2 + M phase (Figures 5b and 5c) .
Discussion
This study has demonstrated that flow cytometric DNA analysis can be used to evaluate the sensitivity of three Ehrlich ascites tumours after in vitro exposure to adriamycin. In in vitro sensitivity testing it is essential to correlate the results with the in vivo sensitivity of the tumours. The data herein presented indicate that drug-induced cell cycle perturbation in vitro correlates well with the in vivo sensitivity of the three Ehrlich ascites tumours. It has been shown that anthracyclines cause a dosedependent cell kill of the sensitive tumour, demonstrated by increase in life-span and decrease in tumour cell volume, whereas no effect was found upon the two resistant tumours (Dan0, 1971; 1972a; 1972b) . Flow cytometric DNA analysis was suitable for monitoring the adriamycin-induced accumulation of cells in the G2+M phase of the sensitive wild-type tumour in the I h incubation experiment as well as in the continuous incubation experiment. However, the results were different in some aspects. Monitoring of the cell cycle changes of the wildtype tumour during continuous incubation was only possible at adriamycin concentrations of < 10-3 mg ml -1, whereas sufficient cell yield was obtained in the 1 h incubation procedure for doses < .0-I mg ml 1. Continuous adriamycin incubation caused an accumulation of cells in G2 + M for concentrations 10-fold lower than after 1 h exposure. The increase of the G2 + M fraction in the continuous incubation experiment was maximal on days 2-4, whereas concentrations of 10-3mgmIP' and 5xlO3mgml-I resulted in an almost complete accumulation of cells in G2 + M on Day 1 in the 1 h experiment. The differences in the results in the two incubation procedures correlate well with results obtained for human lymphoid cell line exposed to adriamycin . The changes in the cell cycle compartments are the net results of the pretreatment fluxs, treatment-induced changes in some of these fluxs and cell loss. The explanation of the differences in the results of the two incubation procedures might be that 1 h adriamycin exposure (10-3mgMml1 and 5x10 -3mgml-) does not affect the G1 and S phases, but induces a block in G2 +M, followed by cell death. Continuous drug exposure resulted in a decreased flux of cells from S to G2+ M and delay in G2 + M phase. Drug-induced changes in the cell cycle are dosedependent. In the two resistant tumours the maximum dose applied (10-mgml-1) also resulted in an accumulation of cells in G2 + M phase (Figure 3b and 3c) . The G2 + M fraction was falling to values almost identical to the controls on Day 4, and the cell yield did not indicate cell death. In the sensitive tumour the adriamycin dose of 10-1 mgml-1 induced a "freezing" of the cell cycle, resulting in no detectable effect (Figure 3a ), a phenomenon previously described with cultured human lymphoblasts exposed to high doses of adriamycin (Krishan & Frei, 1976) and VP-16-213 (Drewinko & .
The continuous incubation procedure is considered the more feasible of the two methods for use as a clinical drug sensitivity test. Continuous exposure involves fewer steps than the 1 h method, the loss of cells caused by washing out adriamycin after I h is thus avoided, and the time interval where a G2 + M accumulation is detectable is longer when the tumour cells are incubated continuously.
In both procedures it is important to test an adequate number of dose levels to ensure doses within the range of concentrations causing a detectable drug effect. The use of too few dose levels involves the risk of testing only low doses, with no effect, or high doses, resulting in the observed "freezing" phenomenon.
A simple estimate of the sensitivity of a tumour to adriamycin could be that concentration of the drug which results in maximum accumulation of the cells in G2 + M. For the wild-type tumour the estimate would be 1O-3mgml-1 and 10l 1mgml -for the resistant tumours after 1 h incubation.
A number of chemotherapeutic agents have a cycle-specific effect, and therefore it may be possible to use the method to evaluate sensitivity to agents other than adriamycin. In a recent study, flow cytometric DNA analysis performed on sequential fine-needle aspirates from human tumours during chemotherapy demonstrated pronounced drug-induced cell cycle perturbations (Vindelqv et al., 1982) . We therefore consider it possible to modify and extend the methods as a sensitivity test for human malignant tumours. However, therapy-induced cell cycle perturbations which are not accompanied by cell kill (Terasima & Tolmach, 1963 ) may prove to be a limitation in using flow cytometry for in vitro sensitivity testing.
The methods described in this study would overcome some of the limitations of the in vitro clonogenic assay (Hamburger & Salmon, 1977) . The methods demand only that the tumour cells are maintained through a single cell cycle; the determination of colony-forming cells is unnecessary. The flow cytometric technique permits the determination of the DNA-index (Barlogie et al., 1978) , which ensures that, as far as DNA content is concerned, the cells tested in vitro are representative of the main cell population of the tumour. Finally, the sensitivity test presented provides conclusive results within a few days. 
